These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35672504)

  • 21. Characteristics and burden of disease in patients with radiographic versus non-radiographic axial spondyloarthritis in the ASRI cohort.
    Quinn S; Maguire S; O'Shea F; O'Neill L; Molloy E; Fearon U; Gallagher P; Veale DJ
    Ir J Med Sci; 2024 Feb; 193(1):443-448. PubMed ID: 37418106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in pharmacotherapies for axial spondyloarthritis.
    Toussirot E
    Expert Opin Pharmacother; 2023; 24(13):1439-1448. PubMed ID: 37318776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mixed methods study to uncover impediments to accurate diagnosis of nonradiographic axial spondyloarthritis in the USA.
    Kiwalkar S; Howard R; Choi D; Deodhar A
    Clin Rheumatol; 2023 Oct; 42(10):2811-2822. PubMed ID: 37347434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial.
    Rusman T; van der Weijden M; Nurmohamed MT; van Denderen CJ; Landewé R; Bet PM; Bijl CV; van der Laken CJ; van der Horst-Bruinsma IE
    Scand J Rheumatol; 2023 Mar; 52(2):137-141. PubMed ID: 35543102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices.
    Kleinert S; Schuch F; Rapp P; Ronneberger M; Wendler J; Sternad P; Popp F; Bartz-Bazzanella P; von der Decken C; Karberg K; Gauler G; Wurth P; Späthling-Mestekemper S; Kuhn C; Vorbrüggen W; Welcker M
    Rheumatol Int; 2024 Apr; 44(4):653-661. PubMed ID: 37805981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review.
    Magrey M; Schwartzman S; de Peyrecave N; Sloan VS; Stark JL
    Medicine (Baltimore); 2022 Apr; 101(15):e29063. PubMed ID: 35475794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?
    Wallis D; Haroon N; Ayearst R; Carty A; Inman RD
    J Rheumatol; 2013 Dec; 40(12):2038-41. PubMed ID: 24187102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
    Wallman JK; Kapetanovic MC; Petersson IF; Geborek P; Kristensen LE
    Arthritis Res Ther; 2015 Dec; 17():378. PubMed ID: 26703005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.
    Webers C; Ortolan A; Sepriano A; Falzon L; Baraliakos X; Landewé RBM; Ramiro S; van der Heijde D; Nikiphorou E
    Ann Rheum Dis; 2023 Jan; 82(1):130-141. PubMed ID: 36270657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-radiographic axial spondyloarthritis in South America. Burden of disease and differential features with respect to ankylosing spondylitis at time of diagnosis. A comprehensive analysis with a focus on images.
    Garcia Salinas R; Jaldin Cespedes R; Gomez RA; Aguerre D; Sommerfleck F
    Int J Rheum Dis; 2022 Oct; 25(10):1169-1175. PubMed ID: 35891615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA).
    Fukui S; Kawaai S; Sawada H; Kishimoto M
    Expert Rev Clin Immunol; 2024 Feb; 20(2):141-153. PubMed ID: 37955181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies.
    Baraliakos X; Deodhar A; van der Heijde D; Magrey M; Maksymowych WP; Tomita T; Xu H; Massow U; Fleurinck C; Ellis AM; Vaux T; Shepherd-Smith J; Marten A; Gensler LS
    Ann Rheum Dis; 2024 Jan; 83(2):199-213. PubMed ID: 37793792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
    Deodhar A; Strand V; Kay J; Braun J
    Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the clinical characteristics and quality of life of male and female patients with non-radiographic axial spondyloarthritis.
    Unal Enginar A
    Int Immunopharmacol; 2023 Oct; 123():110627. PubMed ID: 37494835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study.
    Landewé R; Braun J; Deodhar A; Dougados M; Maksymowych WP; Mease PJ; Reveille JD; Rudwaleit M; van der Heijde D; Stach C; Hoepken B; Fichtner A; Coteur G; de Longueville M; Sieper J
    Ann Rheum Dis; 2014 Jan; 73(1):39-47. PubMed ID: 24013647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis.
    Mease P
    Curr Rheumatol Rep; 2019 Jun; 21(7):35. PubMed ID: 31172311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose Tapering and Discontinuation of Biologic DMARDs in Axial Spondyloarthritis: A Narrative Review (2023 SPARTAN Annual Meeting Proceedings).
    Chaudhary H; Bittar M; Daoud A; Magrey M
    Curr Rheumatol Rep; 2024 May; 26(5):155-163. PubMed ID: 38332457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-radiographic axial spondyloarthritis in Tunisia: main characteristics and detailed comparison with ankylosing spondylitis.
    Ben Abdelghani K; Gzam Y; Fazaa A; Miladi S; Sellami M; Souabni L; Kassab S; Chekili S; Zakraoui L; Laater A
    Clin Rheumatol; 2021 Apr; 40(4):1361-1367. PubMed ID: 32974836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials.
    van der Heijde D; Deodhar A; Baraliakos X; Brown MA; Dobashi H; Dougados M; Elewaut D; Ellis AM; Fleurinck C; Gaffney K; Gensler LS; Haroon N; Magrey M; Maksymowych WP; Marten A; Massow U; Oortgiesen M; Poddubnyy D; Rudwaleit M; Shepherd-Smith J; Tomita T; Van den Bosch F; Vaux T; Xu H
    Ann Rheum Dis; 2023 Apr; 82(4):515-526. PubMed ID: 36649967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of serious infections in biological treatment of patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
    Wang S; He Q; Shuai Z
    Clin Rheumatol; 2018 Feb; 37(2):439-450. PubMed ID: 29290076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.